Skip to main content
. Author manuscript; available in PMC: 2014 Nov 13.
Published in final edited form as: Cancer Invest. 2013 Aug;31(7):500–504. doi: 10.3109/07357907.2013.820321

Table 3.

Five-year survival stratified by stage and histology.

Mucinous Endometrioid

N 5-year survival N 5-year survival
Stage I 971 89.9% (87.6-91.9) 32,494 89.0% (88.6-89.4)
Stage II 24 68.6% (39.1-85.9) 1269 76.4% (73.0-79.5)
Stage III 132 67.6% (58.2-75.4) 3431 58.6% (56.5-61.0)
Stage IV 45 41.6% (26.7-55.9) 1271 30.4% (27.4-33.5)

(95% confidence interval)